Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.

Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014 Aug; 272(2):587-97.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Angiography, Digital Subtraction
Antineoplastic Agents
Biomarkers
Biopsy
Carcinoma, Hepatocellular
Chemoembolization, Therapeutic
Contrast Media
Female
Gadolinium DTPA
Humans
Liver Function Tests
Liver Neoplasms
Magnetic Resonance Angiography
Magnetic Resonance Imaging, Interventional
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Survival Rate
Treatment Outcome
Tumor Burden